Equities researchers at Evercore ISI started coverage on shares of Intuitive Surgical (NASDAQ:ISRG) in a research note issued to investors on Wednesday, MarketBeat reports. The brokerage set an “in-line” rating and a $380.00 price target on the medical equipment provider’s stock. Evercore ISI’s price objective would suggest a potential upside of 0.24% from the stock’s current price.

Other equities research analysts have also recently issued reports about the company. Wells Fargo & Co reissued a “buy” rating on shares of Intuitive Surgical in a report on Monday, October 16th. Wedbush reissued a “buy” rating on shares of Intuitive Surgical in a report on Tuesday, October 10th. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $418.00 price target on the stock in a report on Wednesday, October 25th. Goldman Sachs Group reissued a “buy” rating on shares of Intuitive Surgical in a report on Saturday, November 18th. Finally, BidaskClub cut Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 12th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company. Intuitive Surgical currently has a consensus rating of “Buy” and an average target price of $340.63.

Shares of Intuitive Surgical (NASDAQ ISRG) traded up $3.84 during trading on Wednesday, reaching $379.09. The company had a trading volume of 140,728 shares, compared to its average volume of 678,050. Intuitive Surgical has a one year low of $208.24 and a one year high of $405.05. The company has a market cap of $42,760.00, a PE ratio of 48.98, a P/E/G ratio of 5.13 and a beta of 0.47.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 EPS for the quarter, beating the Zacks’ consensus estimate of $1.99 by $0.78. The business had revenue of $806.10 million for the quarter, compared to analysts’ expectations of $753.25 million. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. The business’s quarterly revenue was up 18.0% on a year-over-year basis. During the same period last year, the firm earned $2.06 earnings per share. research analysts anticipate that Intuitive Surgical will post 7.85 EPS for the current fiscal year.

In other news, insider Craig H. Barratt sold 15,000 shares of the firm’s stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $371.18, for a total transaction of $5,567,700.00. Following the completion of the transaction, the insider now owns 7,500 shares in the company, valued at $2,783,850. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Marshall Mohr sold 6,000 shares of the firm’s stock in a transaction dated Monday, October 30th. The shares were sold at an average price of $372.22, for a total value of $2,233,320.00. Following the transaction, the chief financial officer now owns 12,316 shares of the company’s stock, valued at approximately $4,584,261.52. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 55,944 shares of company stock valued at $21,432,971. Company insiders own 2.20% of the company’s stock.

Institutional investors have recently modified their holdings of the company. Atlantic Trust Group LLC purchased a new position in Intuitive Surgical in the third quarter worth about $80,533,000. AustralianSuper Pty Ltd grew its position in Intuitive Surgical by 22.1% in the third quarter. AustralianSuper Pty Ltd now owns 88,500 shares of the medical equipment provider’s stock worth $92,560,000 after acquiring an additional 16,000 shares in the last quarter. Parametric Portfolio Associates LLC grew its position in Intuitive Surgical by 6.1% in the third quarter. Parametric Portfolio Associates LLC now owns 103,781 shares of the medical equipment provider’s stock worth $108,542,000 after acquiring an additional 5,940 shares in the last quarter. AXA grew its position in Intuitive Surgical by 21.2% in the third quarter. AXA now owns 72,860 shares of the medical equipment provider’s stock worth $76,203,000 after acquiring an additional 12,737 shares in the last quarter. Finally, Hikari Tsushin Inc. grew its position in Intuitive Surgical by 200.0% in the third quarter. Hikari Tsushin Inc. now owns 11,340 shares of the medical equipment provider’s stock worth $3,953,000 after acquiring an additional 7,560 shares in the last quarter. Hedge funds and other institutional investors own 32.80% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Intuitive Surgical (ISRG) Now Covered by Evercore ISI” was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another website, it was stolen and reposted in violation of U.S. and international copyright law. The legal version of this report can be accessed at https://www.americanbankingnews.com/2018/01/03/evercore-isi-begins-coverage-on-intuitive-surgical-isrg.html.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.